ARYx Therapeutics Income Statement 2009-2024 | ARYX

Fifteen years of historical annual and quarterly income statements for ARYx Therapeutics (ARYX).

Annual Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
TTM2009
$0.00$0
$0.00$0
$0.00$0
$7.06$21.04
$9.67$10.20
$0.00$0
$0.00$0
$-16.73$-31.24
$-1.60$-1.93
$-18.33$-33.17
$0.00$0
$-18.33$-33.17
$0.00$0
$-18.33$-33.17
$0.00$0
$-18.33$-33.17
$-15.59$-29.97
$-16.73$-31.24
$-0.62$-1.21
$-0.62$-1.21

Quarterly Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
2010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$0.83$1.00$2.24$2.99$4.99$6.27$6.79
$1.32$2.24$3.78$2.34$2.64$2.62$2.60
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$-2.15$-3.24$-6.02$-5.32$-7.63$-8.89$-9.39
$-0.37$-0.39$-0.37$-0.47$-0.52$-0.50$-0.45
$-2.51$-3.64$-6.39$-5.79$-8.15$-9.39$-9.84
$0$0$0$0$0$0$0
$-2.51$-3.64$-6.39$-5.79$-8.15$-9.39$-9.84
$0$0$0$0$0$0$0
$-2.51$-3.64$-6.39$-5.79$-8.15$-9.39$-9.84
$0$0$0$0$0$0$0
$-2.51$-3.64$-6.39$-5.79$-8.15$-9.39$-9.84
$-1.94$-3.01$-5.77$-4.87$-7.45$-8.55$-9.10
$-2.15$-3.24$-6.02$-5.32$-7.63$-8.89$-9.39
$-0.08$-0.11$-0.22$-0.21$-0.30$-0.34$-0.36
$-0.08$-0.11$-0.22$-0.21$-0.30$-0.34$-0.36